Seres Therapeutics (MCRB) Presents New Preclinical Data Supporting the Development of Microbiome Therapeutics for Immuno-Oncology at AACR

April 17, 2018 12:00 PM

Seres Therapeutics, Inc. (NASDAQ: MCRB) today announced that new preclinical data supporting the development of microbiome therapeutics for immuno-oncology (leveraging ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found